Mr. Christopher Egerton-Warburton
Founding partner and Co-CEO, Lion’s Head
Mr. Christopher Egerton-Warburton is a founding partner and Co-CEO of Lion’s Head Global Partners. He pioneered innovative financing in global health, including IFFIm, GHIC, CEPI, and the Global AMR Investment Fund. Recently, he helped Gavi develop AVMA for African vaccine manufacturing. With extensive experience supporting the World Bank, Rockefeller Foundation and governments.
Prior to establishing Lion’s Head in 2008, Mr. Egerton-Warburton spent 14 years at Goldman Sachs within the Debt Capital Markets group. He holds an MA in biochemistry from Oxford University.